223 related articles for article (PubMed ID: 6128251)
1. [Dependence of the antipsychotic effect of neuroleptics on their dopamine-blocking properties].
Arushanian EB
Farmakol Toksikol; 1982; 45(5):118-26. PubMed ID: 6128251
[No Abstract] [Full Text] [Related]
2. Effects of neuroleptics on the nigroneostriatal and mesocortical dopaminergic systems.
Glowinski J
Res Publ Assoc Res Nerv Ment Dis; 1975; 54():233-46. PubMed ID: 769114
[No Abstract] [Full Text] [Related]
3. [Effect of psychotropic drugs on the central dopamine metabolism (example: neuroleptics)].
Havemann U
Arzneimittelforschung; 1981; Suppl 27():18-22. PubMed ID: 6118158
[No Abstract] [Full Text] [Related]
4. Gamma-type endorphins and brain dopaminergic systems.
van Ree JM; Elands J; Kiraly I; Wolterink G
Prog Clin Biol Res; 1990; 328():287-90. PubMed ID: 1968266
[No Abstract] [Full Text] [Related]
5. Molindone hydrochloride: a review of laboratory and clinical findings.
Owen RR; Cole JO
J Clin Psychopharmacol; 1989 Aug; 9(4):268-76. PubMed ID: 2671060
[TBL] [Abstract][Full Text] [Related]
6. Role of brain dopamine in the antipsychotic effect of neuroleptics. Evidence from studies of amphetamine-neuroleptic interaction.
Randrup A
Mod Probl Pharmacopsychiatry; 1970; 5():60-5. PubMed ID: 5527170
[No Abstract] [Full Text] [Related]
7. Dopamine receptor mechanisms: behavioral and electrophysiological studies.
Ungerstedt U; Ljungberg T; Schultz W
Adv Biochem Psychopharmacol; 1978; 19():311-21. PubMed ID: 29451
[No Abstract] [Full Text] [Related]
8. [Action of etmozin and ethacizin on dopaminergic adenylate cyclase of the striate system of the brain].
Baldenkov GN; Ratner EI; Rozenshtraukh LV; Tkachuk VA
Biull Eksp Biol Med; 1984 Oct; 98(10):448-50. PubMed ID: 6149776
[TBL] [Abstract][Full Text] [Related]
9. [Modulation of dopaminergic receptor sensitivity in the central nervous system: important parameters in synaptic function regulation].
Costentin J
Encephale; 1979; 5(2):121-49. PubMed ID: 38958
[TBL] [Abstract][Full Text] [Related]
10. Clinical evidence for multiple dopamine receptors in man.
Meltzer HY
Commun Psychopharmacol; 1979; 3(6):457-70. PubMed ID: 44694
[No Abstract] [Full Text] [Related]
11. Binding of a conformationally restricted dopamine analogue, 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, to receptors on rat brain synaptic membranes.
Roberts PJ; Woodruff GN; Poat JA
Mol Pharmacol; 1977 May; 13(3):541-7. PubMed ID: 17829
[No Abstract] [Full Text] [Related]
12. Acute and chronic treatment with neuroleptics: similarities and differences in their action on nigrostriatal, mesolimbic, and mesocortical dopaminergic neurons.
Julou L; Scatton B; Glowinski J
Adv Biochem Psychopharmacol; 1977; 16():617-24. PubMed ID: 18904
[No Abstract] [Full Text] [Related]
13. Psychopharmacological implications of dopamine and dopamine antagonists: a critical evaluation of current evidence.
Hornykiewicz O
Annu Rev Pharmacol Toxicol; 1977; 17():545-59. PubMed ID: 17361
[No Abstract] [Full Text] [Related]
14. Chronic neuroleptic treatment and dopamine receptor regulation.
Creese I; Snyder SH
Adv Biochem Psychopharmacol; 1980; 24():89-94. PubMed ID: 6105809
[No Abstract] [Full Text] [Related]
15. No evidence for increased dopamine receptor binding in superresponsive mice after a single dose of neuroleptics.
Hyttel J
Adv Biochem Psychopharmacol; 1980; 24():167-73. PubMed ID: 6105773
[No Abstract] [Full Text] [Related]
16. Early-stage loss of dopamine uptake-site binding in MPTP-treated monkeys.
Graybiel AM; Moratalla R; Quinn B; DeLanney LE; Irwin I; Langston JW
Adv Neurol; 1993; 60():34-9. PubMed ID: 8420148
[No Abstract] [Full Text] [Related]
17. Dopamine-stimulated adenylate cyclase in rat substantia nigra: localization and effects of neuroleptics.
Spano PF; Di Chiara G; Loddo P; Tonon GC; Trabucchi M
Adv Biochem Psychopharmacol; 1977; 16():613-6. PubMed ID: 18903
[No Abstract] [Full Text] [Related]
18. Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity.
Seeger TF; Seymour PA; Schmidt AW; Zorn SH; Schulz DW; Lebel LA; McLean S; Guanowsky V; Howard HR; Lowe JA
J Pharmacol Exp Ther; 1995 Oct; 275(1):101-13. PubMed ID: 7562537
[TBL] [Abstract][Full Text] [Related]
19. Pharmacology and biochemistry of haloperidol.
Niemegeers CJ; Laduron PM
Proc R Soc Med; 1976; 69 suppl 1(Suppl 1):3-8. PubMed ID: 14331
[No Abstract] [Full Text] [Related]
20. [Are the antipsychotic and side-effects of neuroleptics imperfectly known?].
Schulz P
Biomed Pharmacother; 1987; 41(1):31-3. PubMed ID: 2886159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
